Tokyo Tape
Sign in
← Medical Ikkou Group

Annual report

3353.TEDINET S100QTLN
Period2022-03-01 → 2023-02-28
Filed2023-05-25
StandardJapan GAAP
ConsolidatedYes
Data checks22 of 22 passed
Key figures · 145
MetricValuePeriodScopeSource row
Revenue¥33.9bn2022-03-01 → 2023-02-28Cons.Net sales
Revenue¥33.6bn2021-03-01 → 2022-02-28Cons.Net sales
Revenue¥31.6bn2020-03-01 → 2021-02-28dCons.Net sales (5-year summary)
Revenue¥32.0bn2019-03-01 → 2020-02-29dCons.Net sales (5-year summary)
Revenue¥31.2bn2018-03-01 → 2019-02-28dCons.Net sales (5-year summary)
Operating income¥935m2022-03-01 → 2023-02-28Cons.Operating income
Operating income¥1.3bn2021-03-01 → 2022-02-28Cons.Operating income
Ordinary income¥1.2bn2022-03-01 → 2023-02-28Cons.Ordinary income
Ordinary income¥1.4bn2021-03-01 → 2022-02-28Cons.Ordinary income
Ordinary income¥1.2bn2020-03-01 → 2021-02-28dCons.Ordinary income loss (5-year summary)
Ordinary income¥1.2bn2019-03-01 → 2020-02-29dCons.Ordinary income loss (5-year summary)
Ordinary income¥1.1bn2018-03-01 → 2019-02-28dCons.Ordinary income loss (5-year summary)
Profit before tax¥1.3bn2022-03-01 → 2023-02-28Cons.Income before income taxes
Profit before tax¥1.5bn2021-03-01 → 2022-02-28Cons.Income before income taxes
Net income (owners)¥760m2022-03-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income (owners)¥852m2021-03-01 → 2022-02-28Cons.Profit loss attributable to owners of parent
Net income (owners)¥835m2020-03-01 → 2021-02-28dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥802m2019-03-01 → 2020-02-29dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥712m2018-03-01 → 2019-02-28dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥773m2022-03-01 → 2023-02-28Cons.Profit loss
Net income¥869m2021-03-01 → 2022-02-28Cons.Profit loss
Total assets¥27.5bnat 2023-02-28Cons.Assets
Total assets¥29.1bnat 2022-02-28Cons.Assets
Total assets¥28.6bnat 2021-02-28dCons.Total assets (5-year summary)
Total assets¥26.2bnat 2020-02-29dCons.Total assets (5-year summary)
Total assets¥26.2bnat 2019-02-28dCons.Total assets (5-year summary)
Total liabilities¥14.9bnat 2023-02-28Cons.Liabilities
Total liabilities¥17.2bnat 2022-02-28Cons.Liabilities
Net assets / equity¥12.6bnat 2023-02-28Cons.Net assets
Net assets / equity¥11.9bnat 2022-02-28Cons.Net assets
Net assets / equity¥10.5bnat 2021-02-28dCons.Net assets
Net assets / equity¥10.2bnat 2020-02-29dCons.Net assets (5-year summary)
Net assets / equity¥9.6bnat 2019-02-28dCons.Net assets (5-year summary)
Cash and deposits¥6.4bnat 2023-02-28Cons.Cash and deposits
Cash and deposits¥8.0bnat 2022-02-28Cons.Cash and deposits
Cash & equivalents¥6.3bnat 2023-02-28Cons.Cash and cash equivalents
Cash & equivalents¥7.8bnat 2022-02-28Cons.Cash and cash equivalents
Cash & equivalents¥6.8bnat 2021-02-28dCons.Cash and cash equivalents
Cash & equivalents¥5.6bnat 2020-02-29dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥5.2bnat 2019-02-28dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥1.3bn2022-03-01 → 2023-02-28Cons.Net cash provided by used in operating activities
Operating cash flow¥1.1bn2021-03-01 → 2022-02-28Cons.Net cash provided by used in operating activities
Operating cash flow¥1.8bn2020-03-01 → 2021-02-28dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.8bn2019-03-01 → 2020-02-29dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥516m2018-03-01 → 2019-02-28dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥478m2022-03-01 → 2023-02-28Cons.Net cash provided by used in investment activities
Investing cash flow−¥216m2021-03-01 → 2022-02-28Cons.Net cash provided by used in investment activities
Investing cash flow−¥1.2bn2020-03-01 → 2021-02-28dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥375m2019-03-01 → 2020-02-29dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.3bn2018-03-01 → 2019-02-28dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥2.4bn2022-03-01 → 2023-02-28Cons.Net cash provided by used in financing activities
Financing cash flow¥65m2021-03-01 → 2022-02-28Cons.Net cash provided by used in financing activities
Financing cash flow¥591m2020-03-01 → 2021-02-28dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.1bn2019-03-01 → 2020-02-29dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥475m2018-03-01 → 2019-02-28dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥202.22022-03-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥226.922021-03-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥221.312020-03-01 → 2021-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥210.362019-03-01 → 2020-02-29dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥185.952018-03-01 → 2019-02-28dCons.Basic earnings loss per share (5-year summary)
Net assets per share¥3,207.14at 2023-02-28Cons.Net assets per share (5-year summary)
Net assets per share¥3,030.61at 2022-02-28Cons.Net assets per share (5-year summary)
Net assets per share¥2,791.36at 2021-02-28dCons.Net assets per share (5-year summary)
Net assets per share¥2,667.87at 2020-02-29dCons.Net assets per share (5-year summary)
Net assets per share¥2,505.51at 2019-02-28dCons.Net assets per share (5-year summary)
Equity ratio43.8%at 2023-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio39.1%at 2022-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio36.7%at 2021-02-28dCons.Equity to asset ratio (5-year summary)
Equity ratio38.8%at 2020-02-29dCons.Equity to asset ratio (5-year summary)
Equity ratio36.4%at 2019-02-28dCons.Equity to asset ratio (5-year summary)
ROE6.5%2022-03-01 → 2023-02-28Cons.Rate of return on equity (5-year summary)
ROE7.8%2021-03-01 → 2022-02-28Cons.Rate of return on equity (5-year summary)
ROE8.1%2020-03-01 → 2021-02-28dCons.Rate of return on equity (5-year summary)
ROE8.1%2019-03-01 → 2020-02-29dCons.Rate of return on equity (5-year summary)
ROE7.5%2018-03-01 → 2019-02-28dCons.Rate of return on equity (5-year summary)
Employees1,297at 2023-02-28Cons.Number of employees
Employees1,325at 2022-02-28Cons.Number of employees
Employees1,304at 2021-02-28dCons.Number of employees
Employees1,187at 2020-02-29dCons.Number of employees
Employees1,178at 2019-02-28dCons.Number of employees
Revenue¥1.0bn2022-03-01 → 2023-02-28StandaloneOperating revenue1
Revenue¥970m2021-03-01 → 2022-02-28StandaloneOperating revenue1
Operating income¥491m2022-03-01 → 2023-02-28StandaloneOperating income
Operating income¥383m2021-03-01 → 2022-02-28StandaloneOperating income
Ordinary income¥592m2022-03-01 → 2023-02-28StandaloneOrdinary income
Ordinary income¥432m2021-03-01 → 2022-02-28StandaloneOrdinary income
Ordinary income¥319m2020-03-01 → 2021-02-28dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥492m2019-03-01 → 2020-02-29dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥697m2018-03-01 → 2019-02-28dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥613m2022-03-01 → 2023-02-28StandaloneIncome before income taxes
Profit before tax¥461m2021-03-01 → 2022-02-28StandaloneIncome before income taxes
Net income¥526m2022-03-01 → 2023-02-28StandaloneProfit loss
Net income¥397m2021-03-01 → 2022-02-28StandaloneProfit loss
Net income¥355m2020-03-01 → 2021-02-28dStandaloneNet income loss (5-year summary)
Net income¥311m2019-03-01 → 2020-02-29dStandaloneNet income loss (5-year summary)
Net income¥685m2018-03-01 → 2019-02-28dStandaloneNet income loss (5-year summary)
Total assets¥11.8bnat 2023-02-28StandaloneAssets
Total assets¥12.5bnat 2022-02-28StandaloneAssets
Total assets¥12.5bnat 2021-02-28dStandaloneTotal assets (5-year summary)
Total assets¥12.4bnat 2020-02-29dStandaloneTotal assets (5-year summary)
Total assets¥17.0bnat 2019-02-28dStandaloneTotal assets (5-year summary)
Total liabilities¥3.2bnat 2023-02-28StandaloneLiabilities
Total liabilities¥4.2bnat 2022-02-28StandaloneLiabilities
Net assets / equity¥8.6bnat 2023-02-28StandaloneNet assets
Net assets / equity¥8.3bnat 2022-02-28StandaloneNet assets
Net assets / equity¥8.0bnat 2021-02-28dStandaloneNet assets
Net assets / equity¥8.2bnat 2020-02-29dStandaloneNet assets (5-year summary)
Net assets / equity¥8.1bnat 2019-02-28dStandaloneNet assets (5-year summary)
Cash and deposits¥1.8bnat 2023-02-28StandaloneCash and deposits
Cash and deposits¥2.2bnat 2022-02-28StandaloneCash and deposits
EPS (basic)¥140.072022-03-01 → 2023-02-28StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥105.692021-03-01 → 2022-02-28StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥94.222020-03-01 → 2021-02-28dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥81.562019-03-01 → 2020-02-29dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥178.922018-03-01 → 2019-02-28dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥402022-03-01 → 2023-02-28StandaloneDividend paid per share (5-year summary)
Dividend per share¥402021-03-01 → 2022-02-28StandaloneDividend paid per share (5-year summary)
Dividend per share¥802020-03-01 → 2021-02-28dStandaloneDividend paid per share (5-year summary)
Dividend per share¥852019-03-01 → 2020-02-29dStandaloneDividend paid per share (5-year summary)
Dividend per share¥802018-03-01 → 2019-02-28dStandaloneDividend paid per share (5-year summary)
Net assets per share¥2,293.7at 2023-02-28StandaloneNet assets per share (5-year summary)
Net assets per share¥2,196.84at 2022-02-28StandaloneNet assets per share (5-year summary)
Net assets per share¥2,131.98at 2021-02-28dStandaloneNet assets per share (5-year summary)
Net assets per share¥2,143.92at 2020-02-29dStandaloneNet assets per share (5-year summary)
Net assets per share¥2,112.94at 2019-02-28dStandaloneNet assets per share (5-year summary)
Equity ratio73.2%at 2023-02-28StandaloneEquity to asset ratio (5-year summary)
Equity ratio66.3%at 2022-02-28StandaloneEquity to asset ratio (5-year summary)
Equity ratio64.3%at 2021-02-28dStandaloneEquity to asset ratio (5-year summary)
Equity ratio65.9%at 2020-02-29dStandaloneEquity to asset ratio (5-year summary)
Equity ratio47.3%at 2019-02-28dStandaloneEquity to asset ratio (5-year summary)
ROE6.2%2022-03-01 → 2023-02-28StandaloneRate of return on equity (5-year summary)
ROE4.9%2021-03-01 → 2022-02-28StandaloneRate of return on equity (5-year summary)
ROE4.4%2020-03-01 → 2021-02-28dStandaloneRate of return on equity (5-year summary)
ROE3.8%2019-03-01 → 2020-02-29dStandaloneRate of return on equity (5-year summary)
ROE8.7%2018-03-01 → 2019-02-28dStandaloneRate of return on equity (5-year summary)
Shares issued4,070,000at 2023-02-28StandaloneTotal number of issued shares (5-year summary)
Shares issued4,070,000at 2022-02-28StandaloneTotal number of issued shares (5-year summary)
Shares issued2,035,000at 2021-02-28dStandaloneTotal number of issued shares (5-year summary)
Shares issued2,035,000at 2020-02-29dStandaloneTotal number of issued shares (5-year summary)
Shares issued2,035,000at 2019-02-28dStandaloneTotal number of issued shares (5-year summary)
Employees25at 2023-02-28StandaloneNumber of employees
Employees25at 2022-02-28StandaloneNumber of employees
Employees25at 2021-02-28dStandaloneNumber of employees
Employees17at 2020-02-29dStandaloneNumber of employees
Employees481at 2019-02-28dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 83
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2022-03-01 → 2023-02-28¥26m
Reconciling Itemsreconcilingdepreciation2022-03-01 → 2023-02-28¥34m
Reconciling Itemsreconcilingrevenue2022-03-01 → 2023-02-28−¥1.0bn
Reconciling Itemsreconcilingrevenue intersegment2022-03-01 → 2023-02-28−¥1.0bn
Reconciling Itemsreconcilingsegment assetsat 2023-02-28¥7.3bn
Reconciling Itemsreconcilingsegment profit2022-03-01 → 2023-02-28−¥709m
Dispensing Pharmacyreportable segmentcapex2022-03-01 → 2023-02-28¥214m
Dispensing Pharmacyreportable segmentdepreciation2022-03-01 → 2023-02-28¥160m
Dispensing Pharmacyreportable segmentemployeesat 2023-02-28462 pure
Dispensing Pharmacyreportable segmentrevenue2022-03-01 → 2023-02-28¥23.1bn
Dispensing Pharmacyreportable segmentrevenue external2022-03-01 → 2023-02-28¥23.1bn
Dispensing Pharmacyreportable segmentsegment assetsat 2023-02-28¥7.8bn
Dispensing Pharmacyreportable segmentsegment profit2022-03-01 → 2023-02-28¥1.5bn
Health Carereportable segmentcapex2022-03-01 → 2023-02-28¥67m
Health Carereportable segmentdepreciation2022-03-01 → 2023-02-28¥389m
Health Carereportable segmentemployeesat 2023-02-28776 pure
Health Carereportable segmentrevenue2022-03-01 → 2023-02-28¥7.7bn
Health Carereportable segmentrevenue external2022-03-01 → 2023-02-28¥7.7bn
Health Carereportable segmentrevenue intersegment2022-03-01 → 2023-02-28¥600,000
Health Carereportable segmentsegment assetsat 2023-02-28¥9.5bn
Health Carereportable segmentsegment profit2022-03-01 → 2023-02-28−¥29m
Medical Products Wholesalereportable segmentdepreciation2022-03-01 → 2023-02-28¥12m
Medical Products Wholesalereportable segmentemployeesat 2023-02-2833 pure
Medical Products Wholesalereportable segmentrevenue2022-03-01 → 2023-02-28¥3.9bn
Medical Products Wholesalereportable segmentrevenue external2022-03-01 → 2023-02-28¥2.9bn
Medical Products Wholesalereportable segmentrevenue intersegment2022-03-01 → 2023-02-28¥998m
Medical Products Wholesalereportable segmentsegment assetsat 2023-02-28¥1.3bn
Medical Products Wholesalereportable segmentsegment profit2022-03-01 → 2023-02-28¥57m
Real Estatereportable segmentcapex2022-03-01 → 2023-02-28¥6m
Real Estatereportable segmentdepreciation2022-03-01 → 2023-02-28¥37m
Real Estatereportable segmentemployeesat 2023-02-281 pure
Real Estatereportable segmentrevenue2022-03-01 → 2023-02-28¥189m
Real Estatereportable segmentrevenue external2022-03-01 → 2023-02-28¥187m
Real Estatereportable segmentrevenue intersegment2022-03-01 → 2023-02-28¥2m
Real Estatereportable segmentsegment assetsat 2023-02-28¥1.6bn
Real Estatereportable segmentsegment profit2022-03-01 → 2023-02-28¥125m
Total Of Reportable Segments And Otherssegment totalcapex2022-03-01 → 2023-02-28¥286m
Total Of Reportable Segments And Otherssegment totaldepreciation2022-03-01 → 2023-02-28¥598m
Total Of Reportable Segments And Otherssegment totalrevenue2022-03-01 → 2023-02-28¥34.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-03-01 → 2023-02-28¥33.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-03-01 → 2023-02-28¥1.0bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2023-02-28¥20.2bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-03-01 → 2023-02-28¥1.6bn
Reconciling Itemsreconcilingcapex2021-03-01 → 2022-02-28¥153m
Reconciling Itemsreconcilingdepreciation2021-03-01 → 2022-02-28¥40m
Reconciling Itemsreconcilingrevenue2021-03-01 → 2022-02-28−¥1.1bn
Reconciling Itemsreconcilingrevenue intersegment2021-03-01 → 2022-02-28−¥1.1bn
Reconciling Itemsreconcilingsegment assetsat 2022-02-28¥8.0bn
Reconciling Itemsreconcilingsegment profit2021-03-01 → 2022-02-28−¥736m
Dispensing Pharmacyreportable segmentcapex2021-03-01 → 2022-02-28¥176m
Dispensing Pharmacyreportable segmentdepreciation2021-03-01 → 2022-02-28¥144m
Dispensing Pharmacyreportable segmentrevenue2021-03-01 → 2022-02-28¥22.7bn
Dispensing Pharmacyreportable segmentrevenue external2021-03-01 → 2022-02-28¥22.7bn
Dispensing Pharmacyreportable segmentsegment assetsat 2022-02-28¥7.6bn
Dispensing Pharmacyreportable segmentsegment profit2021-03-01 → 2022-02-28¥1.5bn
Health Carereportable segmentcapex2021-03-01 → 2022-02-28¥33m
Health Carereportable segmentdepreciation2021-03-01 → 2022-02-28¥397m
Health Carereportable segmentrevenue2021-03-01 → 2022-02-28¥7.8bn
Health Carereportable segmentrevenue external2021-03-01 → 2022-02-28¥7.8bn
Health Carereportable segmentrevenue intersegment2021-03-01 → 2022-02-28¥600,000
Health Carereportable segmentsegment assetsat 2022-02-28¥10.5bn
Health Carereportable segmentsegment profit2021-03-01 → 2022-02-28¥219m
Medical Products Wholesalereportable segmentcapex2021-03-01 → 2022-02-28¥8m
Medical Products Wholesalereportable segmentdepreciation2021-03-01 → 2022-02-28¥8m
Medical Products Wholesalereportable segmentrevenue2021-03-01 → 2022-02-28¥3.9bn
Medical Products Wholesalereportable segmentrevenue external2021-03-01 → 2022-02-28¥2.8bn
Medical Products Wholesalereportable segmentrevenue intersegment2021-03-01 → 2022-02-28¥1.1bn
Medical Products Wholesalereportable segmentsegment assetsat 2022-02-28¥1.3bn
Medical Products Wholesalereportable segmentsegment profit2021-03-01 → 2022-02-28¥114m
Real Estatereportable segmentdepreciation2021-03-01 → 2022-02-28¥40m
Real Estatereportable segmentrevenue2021-03-01 → 2022-02-28¥233m
Real Estatereportable segmentrevenue external2021-03-01 → 2022-02-28¥232m
Real Estatereportable segmentrevenue intersegment2021-03-01 → 2022-02-28¥2m
Real Estatereportable segmentsegment assetsat 2022-02-28¥1.7bn
Real Estatereportable segmentsegment profit2021-03-01 → 2022-02-28¥130m
Total Of Reportable Segments And Otherssegment totalcapex2021-03-01 → 2022-02-28¥216m
Total Of Reportable Segments And Otherssegment totaldepreciation2021-03-01 → 2022-02-28¥588m
Total Of Reportable Segments And Otherssegment totalrevenue2021-03-01 → 2022-02-28¥34.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-03-01 → 2022-02-28¥33.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-03-01 → 2022-02-28¥1.1bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2022-02-28¥21.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-03-01 → 2022-02-28¥2.0bn
Real Estatereportable segmentemployeesat 2023-02-281 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,435
ItemContextValueUnit
Net salesPrior1YearDuration_jpcrp030000-asr_E03443-000RealEstateReportableSegmentsMember233203000JPY
Net salesPrior1YearDuration_TotalOfReportableSegmentsAndOthersMember34670494000JPY
Net salesPrior1YearDuration_ReconcilingItemsMember-1074503000JPY
Net salesPrior1YearDuration33595990000JPY
Operating incomePrior1YearDuration_jpcrp030000-asr_E03443-000DispensingPharmacyReportableSegmentsMember1549896000JPY
Operating incomePrior1YearDuration_jpcrp030000-asr_E03443-000HealthCareReportableSegmentsMember218558000JPY
Operating incomePrior1YearDuration_jpcrp030000-asr_E03443-000MedicalProductsWholesaleReportableSegmentsMember113755000JPY
Operating incomePrior1YearDuration_jpcrp030000-asr_E03443-000RealEstateReportableSegmentsMember129625000JPY
Operating incomePrior1YearDuration_TotalOfReportableSegmentsAndOthersMember2011835000JPY
Operating incomePrior1YearDuration_ReconcilingItemsMember-735997000JPY
Operating incomePrior1YearDuration1275838000JPY
AssetsPrior1YearInstant_jpcrp030000-asr_E03443-000DispensingPharmacyReportableSegmentsMember7621866000JPY
AssetsPrior1YearInstant_jpcrp030000-asr_E03443-000HealthCareReportableSegmentsMember10518308000JPY
AssetsPrior1YearInstant_jpcrp030000-asr_E03443-000MedicalProductsWholesaleReportableSegmentsMember1312402000JPY
AssetsPrior1YearInstant_jpcrp030000-asr_E03443-000RealEstateReportableSegmentsMember1690238000JPY
AssetsPrior1YearInstant_TotalOfReportableSegmentsAndOthersMember21142815000JPY
AssetsPrior1YearInstant_ReconcilingItemsMember7951441000JPY
AssetsPrior1YearInstant29094256000JPY
Depreciation segment informationPrior1YearDuration_jpcrp030000-asr_E03443-000DispensingPharmacyReportableSegmentsMember143838000JPY
Depreciation segment informationPrior1YearDuration_jpcrp030000-asr_E03443-000HealthCareReportableSegmentsMember396828000JPY
Depreciation segment informationPrior1YearDuration_jpcrp030000-asr_E03443-000MedicalProductsWholesaleReportableSegmentsMember7848000JPY
Depreciation segment informationPrior1YearDuration_jpcrp030000-asr_E03443-000RealEstateReportableSegmentsMember39957000JPY
Depreciation segment informationPrior1YearDuration_TotalOfReportableSegmentsAndOthersMember588474000JPY
Depreciation segment informationPrior1YearDuration_ReconcilingItemsMember39877000JPY
Depreciation segment informationPrior1YearDuration628351000JPY
Impairment loss elPrior1YearDuration_jpcrp030000-asr_E03443-000DispensingPharmacyReportableSegmentsMember5927000JPY
Impairment loss elPrior1YearDuration_jpcrp030000-asr_E03443-000HealthCareReportableSegmentsMember3973000JPY
Impairment loss elPrior1YearDuration_jpcrp030000-asr_E03443-000MedicalProductsWholesaleReportableSegmentsMember－JPY
Impairment loss elPrior1YearDuration_jpcrp030000-asr_E03443-000RealEstateReportableSegmentsMember－JPY
Impairment loss elPrior1YearDuration_TotalOfReportableSegmentsAndOthersMember9900000JPY
Impairment loss elPrior1YearDuration_ReconcilingItemsMember－JPY
Impairment loss elPrior1YearDuration9900000JPY
Increase in property plant and equipment and intangible assetsPrior1YearDuration_jpcrp030000-asr_E03443-000DispensingPharmacyReportableSegmentsMember175602000JPY
Increase in property plant and equipment and intangible assetsPrior1YearDuration_jpcrp030000-asr_E03443-000HealthCareReportableSegmentsMember32549000JPY
Increase in property plant and equipment and intangible assetsPrior1YearDuration_jpcrp030000-asr_E03443-000MedicalProductsWholesaleReportableSegmentsMember8211000JPY
Increase in property plant and equipment and intangible assetsPrior1YearDuration_jpcrp030000-asr_E03443-000RealEstateReportableSegmentsMember－JPY
Increase in property plant and equipment and intangible assetsPrior1YearDuration_TotalOfReportableSegmentsAndOthersMember216363000JPY
Increase in property plant and equipment and intangible assetsPrior1YearDuration_ReconcilingItemsMember153485000JPY
Increase in property plant and equipment and intangible assetsPrior1YearDuration369848000JPY
Revenues from external customersCurrentYearDuration_jpcrp030000-asr_E03443-000DispensingPharmacyReportableSegmentsMember23094707000JPY
Revenues from external customersCurrentYearDuration_jpcrp030000-asr_E03443-000HealthCareReportableSegmentsMember7671388000JPY
Revenues from external customersCurrentYearDuration_jpcrp030000-asr_E03443-000MedicalProductsWholesaleReportableSegmentsMember2944318000JPY
Revenues from external customersCurrentYearDuration_jpcrp030000-asr_E03443-000RealEstateReportableSegmentsMember187182000JPY
Revenues from external customersCurrentYearDuration_TotalOfReportableSegmentsAndOthersMember33897598000JPY
Revenues from external customersCurrentYearDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYearDuration33897598000JPY
Transactions with other segmentsCurrentYearDuration_jpcrp030000-asr_E03443-000DispensingPharmacyReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYearDuration_jpcrp030000-asr_E03443-000HealthCareReportableSegmentsMember600000JPY
Transactions with other segmentsCurrentYearDuration_jpcrp030000-asr_E03443-000MedicalProductsWholesaleReportableSegmentsMember997937000JPY
Transactions with other segmentsCurrentYearDuration_jpcrp030000-asr_E03443-000RealEstateReportableSegmentsMember1866000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 22 of 22 passed
balance sheet identityconsolidated 2022-02-28pass
balance sheet identityconsolidated 2023-02-28pass
balance sheet identitynon_consolidated 2022-02-28pass
balance sheet identitynon_consolidated 2023-02-28pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2021-02-28pass
statement vs summary · net assetsconsolidated 2022-02-28pass
statement vs summary · net assetsconsolidated 2023-02-28pass
statement vs summary · net assetsnon_consolidated 2021-02-28pass
statement vs summary · net assetsnon_consolidated 2022-02-28pass
statement vs summary · net assetsnon_consolidated 2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2021-03-01/2022-02-28pass
statement vs summary · net income attributable to parentconsolidated 2022-03-01/2023-02-28pass
statement vs summary · operating cash flowconsolidated 2021-03-01/2022-02-28pass
statement vs summary · operating cash flowconsolidated 2022-03-01/2023-02-28pass
statement vs summary · revenueconsolidated 2021-03-01/2022-02-28pass
statement vs summary · revenueconsolidated 2022-03-01/2023-02-28pass
statement vs summary · total assetsconsolidated 2022-02-28pass
statement vs summary · total assetsconsolidated 2023-02-28pass
statement vs summary · total assetsnon_consolidated 2022-02-28pass
statement vs summary · total assetsnon_consolidated 2023-02-28pass